MedTech Dive September 21, 2023
Susan Kelly

The new funding will also support product innovation efforts as the company builds a position in the fast-growing robotic surgery market.

UPDATE: Sept. 21, 2023: CMR Surgical has its eye on the U.S. market opportunity. “The US markets offer significant market potential for CMR. We are invested in the FDA process and have been judiciously working with the FDA towards submission,” company spokesperson Ashley Davis-Marin told MedTech Dive Thursday in an email.

Dive Brief:

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Robotics/RPA, Technology, Trends
Don’t Erode Medical Device Trust with Right to Repair
Neuralink, Passive BCIs And The Future Of Neuroadaptive Technology
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
Inaugural Meeting for FDA's Digital Health Advisory Committee to Focus on GenAI-enabled Medical Devices
Blood vessel-like coating could make medical devices safer for patients

Share This Article